Natco Pharma | Business Upturn

Latest Articles

NATCO Pharma launches Generic Everolimus Tablets 1mg in the U.S. market

Corporates · 9:12 AM

blank

Natco Pharma launches generic Bosentan tablets for oral suspension in the US with 180-day exclusivity

Corporates · Aug 20, 2025

blank

Natco Pharma board declares interim dividend of Rs 2 per share for FY26

Stock Market · Aug 12, 2025

blank

NATCO Pharma Q1 Results: Revenue slips marginally to Rs 1,390.6 crore, net profit falls 28.1% YoY

Quarterly Results · Aug 12, 2025

blank

Natco Pharma gets EIR from USFDA for Hyderabad API facility

Corporates · Jul 24, 2025

blank

Natco Pharma offers to acquire 35.75% stake in South Africa’s Adcock Ingram for Rs 2,000 crore

Corporates · Jul 23, 2025

blank

Natco Pharma shares dip 2% after company receives one observation from US FDA following Mekaguda API facility inspection

Stock Market · Jun 16, 2025

blank

Top stocks to watch today, June 16: NTPC, Godrej Properties, ONGC, Oil India, SpiceJet, Natco Pharma and more

Stock Market · Jun 16, 2025

blank

NATCO Pharma receives one observation after US FDA inspection at Mekaguda API facility

Corporates · Jun 13, 2025

blank

Natco Pharma shares jump 4% as Q4 revenue jumps 14.3% YoY to Rs 1,221 crore

Stock Market · May 29, 2025

blank

NATCO Pharma plans to launch generic Risdiplam in India, awaiting court clearance

Corporates · Apr 8, 2025

blank

Natco Pharma shares drop 30% in 2 days following poor Q3 results

Stock Market · Feb 14, 2025

blank

Natco Pharma shares drop 16% as Q3 revenue falls 37% YoY

Stock Market · Feb 13, 2025

blank

Natco Pharma Q3 FY25 Results: Revenue down 37.4% to Rs 475 crore, Net Profit declines 37.8% YoY

Corporates · Feb 12, 2025

By Aditya Bhagchandani

blank

Lupin and Natco Pharma gets USFDA nod for Generic Bosentan tablets

Corporates · Feb 10, 2025

Showing 15 of 26 articles